Related Experiment Videos
Reversal by flunarizine of the decrease in hippocampal acetylcholine release in pentylenetetrazole-kindled rats
1Department of Experimental Biology, University of Cagliari, Italy. mserra@vaxca1.unica.it
Biochemical Pharmacology
|July 14, 1999
Summary
Flunarizine, a calcium channel blocker, prevented a decrease in hippocampal acetylcholine release in rats treated with pentylenetetrazole (PTZ). This suggests flunarizine may protect cholinergic neurons, despite not preventing PTZ-induced seizures.
Area of Science:
- Neuroscience
- Pharmacology
- Neurochemistry
Background:
- Pentylenetetrazole (PTZ) kindling in rats is associated with reduced hippocampal acetylcholine (ACh) release.
- Cholinergic system dysfunction is implicated in various neurological conditions.
Purpose of the Study:
- To investigate the effect of flunarizine on hippocampal ACh release in PTZ-kindled rats.
- To explore the potential therapeutic role of flunarizine in cholinergic impairment.
Main Methods:
- Microdialysis technique in freely moving rats.
- Long-term administration of PTZ to induce kindling.
- Administration of flunarizine and measurement of hippocampal ACh levels.
Main Results:
- PTZ treatment significantly reduced basal hippocampal ACh release.
- Flunarizine administration prevented the PTZ-induced decrease in ACh release.
- Flunarizine did not prevent the expression of PTZ-induced kindling.
Conclusions:
- Flunarizine protects hippocampal cholinergic neurons from PTZ-induced deficits.
- L-type calcium channel blockade may underlie flunarizine's protective effect on ACh release.
- Flunarizine shows potential for treating conditions involving hippocampal cholinergic dysfunction.